Immunogenicity and reactogenicity of trivalent influenza subunit vaccine Influvac (Rm) for the season 2006/2007. An open, baseline-controlled study in two groups of healthy subjects: Adults and elderly
Phase of Trial: Phase III
Latest Information Update: 12 Jun 2013
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Solvay Pharmaceuticals
- 21 Sep 2007 Status changed from in progress to completed.
- 16 Oct 2006 New trial record.